Aptean logo.png
Aptean Launches New, First-to-Market Antibody Search Solution to Support Biologics Research and Development
26 oct. 2020 09h00 HE | Aptean Inc.
ALPHARETTA, Ga., Oct. 26, 2020 (GLOBE NEWSWIRE) -- Today, Aptean, a global provider of mission-critical enterprise software solutions, announced the release of a new solution designed to help...
Dr. Bristow
ARCA biopharma Announces Submission of IND Application to U.S. FDA for AB201 as a Potential Treatment for COVID-19
21 sept. 2020 08h00 HE | ARCA biopharma, Inc.
WESTMINSTER, Colo., Sept. 21, 2020 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically targeted...
Highlights: 2020 Car
Highlights: 2020 Cardiometabolic Health Congress West Live Online
21 août 2020 11h00 HE | Cardiometabolic Health Congress
Boca Raton, Aug. 21, 2020 (GLOBE NEWSWIRE) -- The 4th Annual CMHC West: Complexities in Cardiometabolic Care was held live online on Aug 7-9, 2020, and was chaired by top experts: Christie M....
Dornier MedTech Launches UroX, a new community to boost innovation in the field of urology
05 août 2020 23h55 HE | Advanced MedTech
Singapore, Aug. 06, 2020 (GLOBE NEWSWIRE) -- Dornier MedTech (Dornier), the pioneer of non-invasive Extracorporeal Shockwave Lithotripsy (ESWL) technology and global leader in stone management,...
Orion Biotechnology
Orion Biotechnology Receives Funding to Test OB-002 for Treatment of COVID-19
30 juil. 2020 10h51 HE | Orion Biotechnology Canada Ltd.
Ottawa, Canada, July 30, 2020 (GLOBE NEWSWIRE) -- Orion Biotechnology Canada Ltd., a clinical stage pharmaceutical company focused on precision engineering small protein therapeutics, today...
BDA Logo3.jpg
BetterLife Pharma (OTCQB:BETRF) Looks to Immune Response Drug Interferon a2b as Potential Therapeutic for COVID-19
19 juin 2020 07h56 HE | BDA International
New York City, June 19, 2020 (GLOBE NEWSWIRE) -- BetterLife Pharma (OTCQB:BETRF) (CSE: BETR) (FRANKFURT: NPAT), an emerging clinical stage pharmaceutical development company, announced recently that...
Vivos LOGO.png
InvestorBrandNetwork (IBN) Coverage Initiated for Vivos Therapeutics Inc.
11 juin 2020 08h30 HE | Vivos Therapeutics Inc.
NEW YORK, June 11, 2020 (GLOBE NEWSWIRE) -- via NetworkWire – Vivos Therapeutics Inc., a company focused on addressing the root causes of mild to moderate sleep apnea, today announces it has...
Une voix aux maladie
Une voix aux maladies valvulaires Canada demande que la priorité soit donnée aux patients atteints de maladies valvulaires cardiaques alors que les interventions chirurgicales non urgentes reprennent
03 juin 2020 07h54 HE | Heart Valve Voice Canada
TORONTO, 03 juin 2020 (GLOBE NEWSWIRE) -- Une voix aux maladies valvulaires Canada (HVV), organisation à but non lucratif de défense des patients atteints de maladies valvulaires cardiaques, exhorte...
HVV logo.jpg
Heart Valve Voice Canada Calls for the Prioritization of Heart Valve Disease Patients as Elective Surgeries Begin to Resume
03 juin 2020 07h54 HE | Heart Valve Voice Canada
TORONTO, June 03, 2020 (GLOBE NEWSWIRE) -- Heart Valve Voice (HVV) Canada, a non-profit patient advocacy organization for those with heart valve disease, urges provincial governments and health care...
CBS_logo.jpg
First COVID-19 Convalescent Plasma Donor
29 avr. 2020 16h30 HE | Canadian Blood Services
VANCOUVER, British Columbia, April 29, 2020 (GLOBE NEWSWIRE) -- Canadian Blood Services is proud to be part of CONCOR, a national clinical trial to test the safety and effectiveness of COVID-19...